Obstructive Sleep Apnea in Obese Community-Dwelling Children: The NANOS Study

for the Spanish Sleep Network(Instituto de Salud Carlos III), María Luz Alonso-Álvarez(Instituto de Salud Carlos III), José Cordero-Guevara(Instituto de Salud Carlos III), Joaquín Téran‐Santos(Instituto de Salud Carlos III), Mónica Gonzalez-Martinez(Instituto de Salud Carlos III), María José Jurado(Instituto de Salud Carlos III), Jaime Corral‐Peñafiel(University of the Basque Country), Joaquín Durán‐Cantolla(University of the Basque Country), David Gozal(Comer Children's Hospital), David Gozal(Comer Children's Hospital)
SLEEP
April 30, 2014
Cited by 150Open Access
Full Text

Abstract

INTRODUCTION: Obesity in children is assumed to serve as a major risk factor in pediatric obstructive sleep apnea syndrome (OSAS). However, the prevalence of OSAS in otherwise healthy obese children from the community is unknown. AIM: To determine the prevalence of OSAS in obese children identified and recruited from primary care centers. METHODS: A cross-sectional, prospective, multicenter study. Spanish children ages 3-14 y with a body mass index (BMI) greater than or equal to the 95th percentile for age and sex were randomly selected, and underwent medical history, snoring, and Pediatric Sleep Questionnaire (PSQ) assessments, as well as physical examination, nasopharyngoscopy, and nocturnal polysomnography (NPSG) recordings. RESULTS: Two hundred forty-eight children (54.4% males) with mean age of 10.8 ± 2.6 y were studied with a BMI of 28.0 ± 4.7 kg/m(2) corresponding to 96.8 ± 0.6 percentile when adjusted for age and sex. The mean respiratory disturbance index (RDI), obstructive RDI (ORDI), and obstructive apnea-hypopnea index (OAHI) were 5.58 ± 9.90, 5.06 ± 9.57, and 3.39 ± 8.78/h total sleep time (TST), respectively. Using ≥ 3/h TST as the cutoff for the presence of OSAS, the prevalence of OSAS ranged from 21.5% to 39.5% depending on whether OAHI, ORDI, or RDI were used. CONCLUSIONS: The prevalence of obstructive sleep apnea syndrome (OSAS) in obese children from the general population is high. Obese children should be screened for the presence of OSAS. ClinicalTrials.gov identifier: NCT01322763.


Related Papers

No related papers found

Powered by citation graph analysis